122 related articles for article (PubMed ID: 3311213)
1. Microenvironmental cytokines and expression of erythroid heme metabolic enzymes.
Brown A; Lutton JD; Nelson J; Abraham NG; Levere RD
Blood Cells; 1987; 13(1-2):123-36. PubMed ID: 3311213
[TBL] [Abstract][Full Text] [Related]
2. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone.
Li Y; Wu XR; Li XF; Suriguga ; Yu CH; Li YR; Yi ZC
Toxicology; 2013 Oct; 312():108-14. PubMed ID: 23973255
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
Roodman GD; Bird A; Hutzler D; Montgomery W
Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin controls heme metabolic enzymes in normal human bone marrow culture.
Abraham NG; Nelson JC; Ahmed T; Konwalinka G; Levere RD
Exp Hematol; 1989 Sep; 17(8):908-13. PubMed ID: 2767184
[TBL] [Abstract][Full Text] [Related]
5. Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-alpha.
Li XF; Anderson J; Hutzler D; Roodman GD
Exp Hematol; 1989 Dec; 17(11):1059-62. PubMed ID: 2555212
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
7. Uroporphyrinogen I synthase assay as an evaluation of the in vitro development of human BFU-E and CFU-E.
Claustres M; Bellet H; de Bornier BM
Biomed Pharmacother; 1985; 39(3):150-4. PubMed ID: 4063465
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of azidothymidine-induced erythroid toxicity by hemin and stem cell factor in immune-suppressed mice.
Hamburger AW; Chen RB
Exp Hematol; 1994 Apr; 22(4):348-52. PubMed ID: 7512046
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
[TBL] [Abstract][Full Text] [Related]
10. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
11. Phenolic metabolites of benzene inhibited the erythroid differentiation of K562 cells.
Wu XR; Xue M; Li XF; Wang Y; Wang J; Han QL; Yi ZC
Toxicol Lett; 2011 Jun; 203(3):190-9. PubMed ID: 21414390
[TBL] [Abstract][Full Text] [Related]
12. Heme metabolism and erythropoiesis in abnormal iron states: role of delta-aminolevulinic acid synthase and heme oxygenase.
Abraham NG; Lutton JD; Levere RD
Exp Hematol; 1985 Sep; 13(8):838-43. PubMed ID: 3840094
[TBL] [Abstract][Full Text] [Related]
13. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures.
Lu L; Welte K; Gabrilove JL; Hangoc G; Bruno E; Hoffman R; Broxmeyer HE
Cancer Res; 1986 Sep; 46(9):4357-61. PubMed ID: 3089590
[TBL] [Abstract][Full Text] [Related]
15. Erythroid colony formation and effect of hemin in vitro in hereditary sideroblastic anemias.
Partanen S; Pasanen A; Juvonen E; Tenhunen R; Ruutu T
Exp Hematol; 1988 May; 16(4):313-5. PubMed ID: 3360067
[TBL] [Abstract][Full Text] [Related]
16. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
Hangoc G; Williams DE; Falkenburg JH; Broxmeyer HE
J Immunol; 1989 Jun; 142(12):4329-34. PubMed ID: 2656864
[TBL] [Abstract][Full Text] [Related]
17. Interactive inhibition of erythroid 59Fe utilization by benzene metabolites in female mice.
Guy RL; Dimitriadis EA; Hu PD; Cooper KR; Snyder R
Chem Biol Interact; 1990; 74(1-2):55-62. PubMed ID: 2322953
[TBL] [Abstract][Full Text] [Related]
18. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.
Mangan KF; D'Alessandro L; Mullaney MT
J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910
[TBL] [Abstract][Full Text] [Related]
19. The role of haem biosynthetic and degradative enzymes in erythroid colony development: the effect of haemin.
Ibrahim NG; Lutton JD; Levere RD
Br J Haematol; 1982 Jan; 50(1):17-28. PubMed ID: 6895697
[No Abstract] [Full Text] [Related]
20. Mechanisms of erythroid suppression in the anemia of chronic disease.
Roodman GD
Blood Cells; 1987; 13(1-2):171-84. PubMed ID: 2822178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
